IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-10910-w.html
   My bibliography  Save this article

AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

Author

Listed:
  • Vincenzo Salpietro

    (UCL Queen Square Institute of Neurology
    Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto “Giannina Gaslini”
    University of Genoa)

  • Christine L. Dixon

    (UCL Queen Square Institute of Neurology)

  • Hui Guo

    (University of Washington School of Medicine
    Central South University)

  • Oscar D. Bello

    (UCL Queen Square Institute of Neurology)

  • Jana Vandrovcova

    (UCL Queen Square Institute of Neurology)

  • Stephanie Efthymiou

    (UCL Queen Square Institute of Neurology
    UCL Queen Square Institute of Neurology)

  • Reza Maroofian

    (UCL Queen Square Institute of Neurology)

  • Gali Heimer

    (Tel Aviv University)

  • Lydie Burglen

    (Centre de Référence des Malformations et Maladies Congénitales du Cervelet, Département de Génétique et Embryologie Médicale, APHP, Hôpital Trousseau)

  • Stephanie Valence

    (Centre de Référence des Malformations et Maladies Congénitales du Cervelet, Service de Neurologie Pédiatrique, APHP, Hôpital Trousseau)

  • Erin Torti

    (GeneDx)

  • Moritz Hacke

    (Heidelberg University)

  • Julia Rankin

    (Royal Devon and Exeter NHS Foundation Trust)

  • Huma Tariq

    (UCL Queen Square Institute of Neurology)

  • Estelle Colin

    (University Hospital
    MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University)

  • Vincent Procaccio

    (University Hospital
    MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University)

  • Pasquale Striano

    (Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto “Giannina Gaslini”
    University of Genoa)

  • Kshitij Mankad

    (Great Ormond Street Hospital for Children)

  • Andreas Lieb

    (UCL Queen Square Institute of Neurology)

  • Sharon Chen

    (Northwell Health/Hofstra University SOM)

  • Laura Pisani

    (Northwell Health/Hofstra University SOM)

  • Conceicao Bettencourt

    (Department of Clinical and Movement Neurosciences and Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology)

  • Roope Männikkö

    (UCL Queen Square Institute of Neurology)

  • Andreea Manole

    (UCL Queen Square Institute of Neurology)

  • Alfredo Brusco

    (University of Torino)

  • Enrico Grosso

    (University of Torino)

  • Giovanni Battista Ferrero

    (University of Torino)

  • Judith Armstrong-Moron

    (University Hospital Sant Joan de Deu Barcelona)

  • Sophie Gueden

    (University Hospital)

  • Omer Bar-Yosef

    (Tel Aviv University)

  • Michal Tzadok

    (Tel Aviv University)

  • Kristin G. Monaghan

    (GeneDx)

  • Teresa Santiago-Sim

    (GeneDx)

  • Richard E. Person

    (GeneDx)

  • Megan T. Cho

    (GeneDx)

  • Rebecca Willaert

    (GeneDx)

  • Yongjin Yoo

    (Seoul National University)

  • Jong-Hee Chae

    (Seoul National University)

  • Yingting Quan

    (Central South University)

  • Huidan Wu

    (Central South University)

  • Tianyun Wang

    (University of Washington School of Medicine
    Central South University)

  • Raphael A. Bernier

    (University of Washington)

  • Kun Xia

    (Central South University)

  • Alyssa Blesson

    (Center for Autism and Related Disorders, Kennedy Krieger Institute)

  • Mahim Jain

    (Center for Autism and Related Disorders, Kennedy Krieger Institute)

  • Mohammad M. Motazacker

    (University of Amsterdam)

  • Bregje Jaeger

    (Amsterdam UMC)

  • Amy L. Schneider

    (University of Melbourne, Austin Health, Melbourne)

  • Katja Boysen

    (University of Melbourne, Austin Health, Melbourne)

  • Alison M. Muir

    (University of Washington)

  • Candace T. Myers

    (University of Washington)

  • Ralitza H. Gavrilova

    (Mayo Clinic)

  • Lauren Gunderson

    (Mayo Clinic)

  • Laura Schultz-Rogers

    (Mayo Clinic)

  • Eric W. Klee

    (Mayo Clinic)

  • David Dyment

    (University of Ottawa)

  • Matthew Osmond

    (University of Ottawa
    McGill University Health Centre
    Genome Québec Innovation Center)

  • Mara Parellada

    (Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM)

  • Cloe Llorente

    (Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Maranon, Universidad Complutense, CIBERSAM)

  • Javier Gonzalez-Peñas

    (Hospital Gregorio Maranon, IiSGM, School of Medicine, Calle Dr Esquerdo, 46)

  • Angel Carracedo

    (Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), CIMUS, Universidade de Santiago de Compostela
    Fundación Pública Galega de Medicina Xenómica- IDIS- Servicio Galego de Saúde (SERGAS), 15706)

  • Arie Haeringen

    (Leiden University Medical Center)

  • Claudia Ruivenkamp

    (Leiden University Medical Center)

  • Caroline Nava

    (University Hôpital Pitié-Salpêtrière)

  • Delphine Heron

    (University Hôpital Pitié-Salpêtrière)

  • Rosaria Nardello

    (University of Palermo)

  • Michele Iacomino

    (Laboratory of Neurogenetics and Neuroscience, IRCCS Istituto “Giannina Gaslini”)

  • Carlo Minetti

    (Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto “Giannina Gaslini”
    University of Genoa)

  • Aldo Skabar

    (University of Trieste)

  • Antonella Fabretto

    (University of Trieste)

  • Miquel Raspall-Chaure

    (University Hospital Vall d’Hebron, Universitat Autònoma de Barcelona)

  • Michael Chez

    (Neuroscience Medical Group, 1625 Stockton Boulevard, Suite 104)

  • Anne Tsai

    (Children’s Hospital Colorado)

  • Emily Fassi

    (Washington University School of Medicine)

  • Marwan Shinawi

    (Washington University School of Medicine)

  • John N. Constantino

    (Washington University School of Medicine)

  • Rita De Zorzi

    (University of Trieste)

  • Sara Fortuna

    (University of Trieste)

  • Fernando Kok

    (University of Sao Paulo
    Mendelics Genomic Analysis)

  • Boris Keren

    (University Hôpital Pitié-Salpêtrière)

  • Dominique Bonneau

    (University Hospital
    MitoLab, UMR CNRS 6015-INSERM U1083, MitoVasc Institute, Angers University)

  • Murim Choi

    (Seoul National University)

  • Bruria Benzeev

    (Tel Aviv University)

  • Federico Zara

    (Laboratory of Neurogenetics and Neuroscience, IRCCS Istituto “Giannina Gaslini”)

  • Heather C. Mefford

    (University of Washington)

  • Ingrid E. Scheffer

    (University of Melbourne, Austin Health, Melbourne)

  • Jill Clayton-Smith

    (Central Manchester University Hospitals NHS Foundation Trust
    University of Manchester)

  • Alfons Macaya

    (University Hospital Vall d’Hebron, Universitat Autònoma de Barcelona)

  • James E. Rothman

    (UCL Queen Square Institute of Neurology
    Yale University School of Medicine)

  • Evan E. Eichler

    (University of Washington School of Medicine
    University of Washington)

  • Dimitri M. Kullmann

    (UCL Queen Square Institute of Neurology)

  • Henry Houlden

    (UCL Queen Square Institute of Neurology)

Abstract

AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations of GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca2+-impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients with intellectual disability (ID) and neurodevelopmental abnormalities including autism spectrum disorder (ASD), Rett syndrome-like features, and seizures or developmental epileptic encephalopathy (DEE). In functional expression studies, mutations lead to a decrease in agonist-evoked current mediated by mutant subunits compared to wild-type channels. When GluA2 subunits are co-expressed with GluA1, most GRIA2 mutations cause a decreased current amplitude and some also affect voltage rectification. Our results show that de-novo variants in GRIA2 can cause neurodevelopmental disorders, complementing evidence that other genetic causes of ID, ASD and DEE also disrupt glutamatergic synaptic transmission.

Suggested Citation

  • Vincenzo Salpietro & Christine L. Dixon & Hui Guo & Oscar D. Bello & Jana Vandrovcova & Stephanie Efthymiou & Reza Maroofian & Gali Heimer & Lydie Burglen & Stephanie Valence & Erin Torti & Moritz Hac, 2019. "AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders," Nature Communications, Nature, vol. 10(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10910-w
    DOI: 10.1038/s41467-019-10910-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-10910-w
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-019-10910-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mara H. Cowen & Dustin Haskell & Kristi Zoga & Kirthi C. Reddy & Sreekanth H. Chalasani & Michael P. Hart, 2024. "Conserved autism-associated genes tune social feeding behavior in C. elegans," Nature Communications, Nature, vol. 15(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10910-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.